Investor Relations

Shareholder Communication Policy

Health Karma Inc. Effective: December 1, 2024
Health Karma Inc. is committed to maintaining transparency and ensuring effective communication with our shareholders.

Health Karma Inc. is committed to maintaining transparency and ensuring effective communication with our shareholders. In compliance with SEC regulations and to maintain the integrity and fairness of information shared, the following communication policy has been implemented.

01
Permitted Communication Channels

Shareholder inquiries and communications will only be accepted via email directed to the Director of Investor Relations at IRSupport@healthkarmagroup.com, or via a secure message through the contact form on our website.

02
Restricted Communication Methods

To maintain consistency and accuracy in our communications and to safeguard against the inadvertent disclosure of material non-public information, we are unable to respond to inquiries or communications via:

  • Direct phone calls to executives
  • Text messages
  • Social media direct messages or posts
  • Any other communication platform not listed above
03
Response Process

All inquiries will be reviewed and responded to by the Director of Investor Relations or an authorized representative in a timely manner. Please ensure that your communication includes:

  1. Your full name
  2. Your contact information
  3. A clear description of your inquiry
04
Annual & Quarterly Reports

We encourage shareholders to refer to our publicly available reports, filed with the SEC, for detailed updates on the Company's financial and operational performance. Health Karma Inc. operates under the legal entity MediXall Group Inc. (OTC Pink: MDXL), and all SEC filings are made under this entity name. Reports can be accessed on the SEC's EDGAR database by searching for MediXall Group Inc.:

View All Filings on SEC EDGAR →

05
Further Assistance

Health Karma is dedicated to addressing all shareholder concerns while adhering to SEC regulations and company policies, including Regulation Fair Disclosure (Reg FD). This policy is subject to change and does not constitute legal advice or a contractual obligation.

Shareholder Inquiries?

Contact our investor relations team at IRSupport@healthkarmagroup.com.

Contact Us